title: Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
abstract: Tumor-specific molecules are needed across diverse areas of oncology for use in early detection, diagnosis, prognosis and therapy. Large and growing public databases of transcriptome sequencing data (RNA-seq) derived from tumors and normal tissues hold the potential of yielding tumor-specific molecules, but because the data are new they have not been fully explored for this purpose. We have developed custom bioinformatic algorithms and used them with 296 high-grade serous ovarian (HGS-OvCa) tumor and 1,839 normal RNA-seq datasets to identify mRNA isoforms with tumor-specific expression. We rank prioritized isoforms by likelihood of being expressed in HGS-OvCa tumors and not in normal tissues and analyzed 671 top-ranked isoforms by high-throughput RT-qPCR. Six of these isoforms were expressed in a majority of the 12 tumors examined but not in 18 normal tissues. An additional 11 were expressed in most tumors and only one normal tissue, which in most cases was fallopian or colon. Of the 671 isoforms, the topmost 5% (n = 33) ranked based on having tumor-specific or highly restricted normal tissue expression by RT-qPCR analysis are enriched for oncogenic, stem cell/cancer stem cell, and early development loci--including ETV4, FOXM1, LSR, CD9, RAB11FIP4, and FGFRL1. Many of the 33 isoforms are predicted to encode proteins with unique amino acid sequences, which would allow them to be specifically targeted for one or more therapeutic strategies--including monoclonal antibodies and T-cell-based vaccines. The systematic process described herein is readily and rapidly applicable to the more than 30 additional tumor types for which sufficient amounts of RNA-seq already exist.
authors.affiliation: Moores Cancer Center, Department of Pediatrics and Rady Children's Hospital.
authors.forename: Christian L
authors.initials: CL
authors.lastname: Barrett
authors.affiliation: Moores Cancer Center, Bioinformatics and Systems Biology.
authors.forename: Christopher
authors.initials: C
authors.lastname: DeBoever
authors.affiliation: Institute for Genomic Medicine.
authors.forename: Kristen
authors.initials: K
authors.lastname: Jepsen
authors.affiliation: Department of Medicine.
authors.forename: Cheryl C
authors.initials: CC
authors.lastname: Saenz
authors.affiliation: Moores Cancer Center, Department of Medicine, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093 dcarson@ucsd.edu.
authors.forename: Dennis A
authors.initials: DA
authors.lastname: Carson
authors.affiliation: Moores Cancer Center, Department of Pediatrics and Rady Children's Hospital, Institute for Genomic Medicine.
authors.forename: Kelly A
authors.initials: KA
authors.lastname: Frazer
mesh_terms: D005260:Female; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D012333:RNA, Messenger / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction; D059467:Transcriptome
chemical_list: D012333:RNA, Messenger
keywords: RNA-seq; bioinformatics; diagnostics; ovarian cancer; therapeutics